Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.

MLA

de Keijzer, Mark J., et al. “Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.” Methods in Molecular Biology (Clifton, N.J.), vol. 2451, 2022, pp. 285–403. EBSCOhost, https://doi.org/10.1007/978-1-0716-2099-1_19.

APA

de Keijzer, M. J., de Klerk, D. J., de Haan, L. R., van Kooten, R. T., Franchi, L. P., Dias, L. M., Kleijn, T. G., van Doorn, D. J., & Heger, M. (2022). Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy. Methods in Molecular Biology (Clifton, N.J.), 2451, 285–403. https://doi.org/10.1007/978-1-0716-2099-1_19

Chicago

de Keijzer, Mark J, Daniel J de Klerk, Lianne R de Haan, Robert T van Kooten, Leonardo P Franchi, Lionel M Dias, Tony G Kleijn, Diederick J van Doorn, and Michal Heger. 2022. “Inhibition of the HIF-1 Survival Pathway as a Strategy to Augment Photodynamic Therapy Efficacy.” Methods in Molecular Biology (Clifton, N.J.) 2451: 285–403. doi:10.1007/978-1-0716-2099-1_19.